Trademark: 90601140
Status Date
Monday, March 11, 2024
Filing Date
Wednesday, March 24, 2021
Published for Opposition
Tuesday, December 14, 2021
Abandoned Date
Monday, March 11, 2024
5 pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
The mark consists of a circle with interlocking halves having interdigitated fingers.
Mar 11, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Mar 11, 2024
Abandonment - No Use Statement Filed
Jul 26, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 24, 2023
Sou Extension 3 Granted
Jul 24, 2023
Sou Extension 3 Filed
Jul 24, 2023
Sou Teas Extension Received
Feb 10, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 8, 2023
Sou Extension 2 Granted
Feb 8, 2023
Sou Extension 2 Filed
Feb 8, 2023
Sou Teas Extension Received
Jul 23, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 21, 2022
Sou Extension 1 Granted
Jul 21, 2022
Sou Extension 1 Filed
Jul 21, 2022
Sou Teas Extension Received
Feb 8, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 14, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 14, 2021
Published For Opposition
Nov 24, 2021
Notification Of Notice Of Publication E-Mailed
Nov 5, 2021
Approved For Pub - Principal Register
Nov 5, 2021
Examiner's Amendment Entered
Nov 5, 2021
Notification Of Examiners Amendment E-Mailed
Nov 5, 2021
Examiners Amendment E-Mailed
Nov 5, 2021
Examiners Amendment -Written
Oct 29, 2021
Assigned To Examiner
Jun 30, 2021
Notice Of Design Search Code E-Mailed
Jun 29, 2021
New Application Office Supplied Data Entered
Mar 27, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24